Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Nicholas Vogt, M.D., Ph.D.

Concepts (79)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Nicholas Vogt's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Nicholas Vogt has written about over time.
Genotype, 1 publications between 2013 and 2013, average publication date January 2013. Serotonin Plasma Membrane Transport Proteins, 1 publications between 2013 and 2013, average publication date January 2013. Methylamines, 1 publications between 2018 and 2018, average publication date December 2018. Cerebral Cortex, 3 publications between 2020 and 2021, average publication date August 2020. Alzheimer Disease, 7 publications between 2017 and 2023, average publication date November 2020. tau Proteins, 5 publications between 2017 and 2023, average publication date February 2021. Neurites, 1 publications between 2021 and 2021, average publication date May 2021. Cholesterol, 1 publications between 2021 and 2021, average publication date July 2021. Hydroxymethylglutaryl-CoA Reductase Inhibitors, 1 publications between 2021 and 2021, average publication date July 2021. Simvastatin, 1 publications between 2021 and 2021, average publication date July 2021. Amyloid beta-Peptides, 4 publications between 2018 and 2023, average publication date December 2021. Amyloid, 2 publications between 2021 and 2023, average publication date August 2022.

To see the data from this visualization as text, click here.
Vogt's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (79)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.